Uniform criteria for the diagnosis of myocardial infarction;Enhetlig diagnostik av hjärtinfarkt: Snabb utveckling på svenska sjukhus

Lakartidningen

Volumn , Issue 6, 1998, Pages 515-520

  Jernberg, Tomas ^a   Lindahl, Bertil ^a   Wallentin, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; ISOENZYME; TROPONIN;

ARTICLE; BLOOD; CLINICAL PRACTICE; CORONARY CARE UNIT; ELECTROCARDIOGRAPHY; ENZYMOLOGY; HEALTH CARE QUALITY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITAL INFORMATION SYSTEM; HUMAN; MONITORING; QUESTIONNAIRE; STANDARD; SWEDEN;

BIOLOGICAL MARKERS; CORONARY CARE UNITS; CREATINE KINASE; ELECTROCARDIOGRAPHY; HUMANS; ISOENZYMES; MONITORING, PHYSIOLOGIC; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PHYSICIAN'S PRACTICE PATTERNS; POINT-OF-CARE SYSTEMS; QUALITY ASSURANCE, HEALTH CARE; QUESTIONNAIRES; SWEDEN; TROPONIN;

EID: 11544367944     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Nilsson G, Agert G. Vad är en hjärtinfarkt? Kvalitetssäkring, grundad på mortalitetssiffror blir missvisande om diagnossättningen varierar. Läkartidningen 1994; 91: 28-9.
2. Agert G, Nilsson G. Vad är en hjärtinfarkt? Teknisk diagnostik varierar mellan sjukhus. Enhetlighet krävs för kvalitetsjämförelser. Läkartidningen 1995; 92: 381-5.
3. Lindahl B, Venge P, Wallentin L, FRISC study group. Relation between Troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651-7.
4. Andersen K, Eriksson P, Dellborg M. Ischemia detected by continuous on-line vectorcardiographic monitoring predicts unfavourable outcome in patients admitted with probable unstable coronary artery disease. Coron Artery Dis 1996; 7: 753-60.
5. Lindahl B, Venge P, Wallentin L, BIO-MACS study group. Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. Coron Artery Dis 1995; 6: 321-8.
6. Adams JD, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993; 88: 750-63.
7. Larue C, Calzolary C, Bertinchant JP, Leclercq F, Grolleau R, Pau B. Cardiacspecific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem 1993; 39: 972-9.
8. Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis. Ann Intern Med 1986; 105: 221-33.
9. Mair J, Artner DE, Dienstl A, Lechleiter P, Morass B, Smidt J et al. Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB. Am J Cardiol 1991; 68: 1545-50.
10. Dellborg M, Steg PG, Simoons M, Dietz R, Sen S, van den Brand M et al. Vectorcardiographic monitoring to assess early vessel patency after reperfusion therapy for acute myocardial infarction. Eur Heart J 1995; 16: 21-9.
11. Patel DJ, Holdright DR, Knight CJ, Mulcahy D, Thakrar B, Wright C et al. Early continuous ST segment monitoring in unstable angina: prognostic value additional to the clinical characteristics and the admission electrocardiogram. Heart 1996; 75: 222-8.
12. Klootwijk P, Langer A, Meij S, Green C, Voldkamp RF, Ross AM et al. Noninvasive prediction of reperfusion and coronary patency by continuous ST segment monitoring in the GUSTO-I trial. Eur Heart J 1996; 17: 689-98.